Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OBN Supports Stem Cell Patentability Consortium Letter

Published: Wednesday, July 17, 2013
Last Updated: Wednesday, July 17, 2013
Bookmark and Share
Letter calls for patentability of products derived from pluripotent stem cells.

Abingdon, UK - OBN, the membership organisation supporting and bringing together the UK's emerging life sciences companies, corporate partners and investors, announces its participation in the Stem Cell Patentability Consortium aimed at protecting the interests of life science companies working in the stem cell field.

Stem cell-based therapies hold much promise for the treatment of a variety of acquired and inherited diseases and for the formation of replacement organs.  The development of such products relies on the manipulation of human embryonic stem cells and its commercial viability is currently in the balance as the European Court of Justice considers the meaning of the term “human embryo” in the context of patenting  - covered by the Legal Protection of Biotechnological Inventions Directive 98/44/EC.

As the law stands a patent which includes the use of a “human embryo” for industrial or commercial purposes cannot be patented.  The Consortium, created and led by law firm Matthew Arnold & Baldwin LLP (MAB), has been formed to support and argue the view that the use of pluripotent stem cells derived from an unfertilised embryo through parthenogenesis should not be regarded as “human embryos” as they are not capable of development of a viable human being.  The Consortium argues that patentability of this technology is crucial to the commercial viability of the embryonic stem cell research, the public interest for the treatment of human illness and the competitive position of the EU.

The Consortium has drafted a letter to be sent to the UK IPO who is positioned to advise the UK Government on its response to the European Court of Justice over the issue.   The strength of this submission is increased by the number and quality of signatories and OBN is supporting this initiative with its contacts within the stem cell industry.  If you are interested in influencing the outcome of this debate please become a signatory.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
1960s Antibiotics Show Promise for TB Therapy
Research suggests antibiotics introduced in 1963 to treat bacterial infections show promise for tuberculosis therapy.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Studies Explore the Science of Cardiovascular Diseases
Two studies highlight how basic science research insights are key to future treatment breakthroughs.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Using Stem Cells to Grow a 3D Lung-in-a-Dish
Researchers have created 3D lung-like tissue from lung-derived stem cells. The tissue can be used to study lung diseases.
MRI Guidance Aids Stem Cell Delivery
Scientists have delivered stem cells to the brain with unprecedented precision, infusing the cells under real-time MRI guidance.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Stem Cell Transplant Without Radiation or Chemotherapy
Researchers have successfully performed stem cell transplants without using radiation or chemotherapy.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!